Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06290869 · ClinicalTrials.gov registry record · Phase 3
Tobacco Education and Lung Health Study (TEAL)
A Phase 3 study of Smoking Cessation, sponsored by Georgetown University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 1,188
- Enrollment target
- 1
- Study location
NCT06290869: Recruiting Phase 3 study of Smoking Cessation, sponsored by Georgetown University.
NCT06290869 is a Phase 3 study of Smoking Cessation that is actively recruiting participants, run by Georgetown University. The registered enrollment target is 1,188 participants, above the 468-participant average among 188 other Smoking Cessation trials with a reported enrollment target (154% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06290869, a Phase 3 study of Smoking Cessation, is actively recruiting participants, sponsored by Georgetown University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 1,188 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Objective To compare two smoking cessation interventions among individuals undergoing lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes and 6-month self-reported and bioverified abstinence from cigarettes. Secondary Objectives 1) To evaluate reach and engagement overall and by subgroup (e.g., race and ethnicity, underinsured, readiness to quit). 2) To conduct an economic analysis to evaluate intervention costs from the health system perspective.
Primary Outcome
Biochemically verified 7-day point prevalence abstinence rates, comparing the Health System (MHS) arm and the Quitline (QL-E) arm
Conditions Studied
Interventions
- BEHAVIORAL Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention
- BEHAVIORAL E-Referral to the Tobacco Quitline
Study Locations (1)
District of Columbia
- Georgetown University Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,188 participants |
| Start Date | 2024-02-22 |
| Est. Completion | 2028-03-01 |
| Phase | Phase 3 |
What NCT06290869 shows while recruiting
NCT06290869 is an interventional study that assigns participants to a tested intervention. Its 1,188 participants enrollment target places it among the larger protocols in the corpus, above the 468-participant average among 188 other Smoking Cessation trials with a reported enrollment target (154% higher).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention is the first listed.
NCT06290869 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06290869 about?
NCT06290869 is a clinical study titled "Tobacco Education and Lung Health Study (TEAL)". Primary Objective To compare two smoking cessation interventions among individuals undergoing lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes and 6-month self-reported and bioverified abstinence from cigarettes. Secondary Objectives 1) To evaluate reach...
What is the current status of trial NCT06290869?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 1,188 participants. The study started on 2024-02-22. Estimated completion is 2028-03-01.
What conditions does trial NCT06290869 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT06290869?
The interventions under investigation include: Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention (BEHAVIORAL), E-Referral to the Tobacco Quitline (BEHAVIORAL).
Who is sponsoring clinical trial NCT06290869?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06290869 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06290869's enrollment target sits among peer trials
1,188 19th of 188 higher than 170 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
V+PSF-M for Tobacco Cessation in HIV Care in India
RECRUITING · Phase 3
-
Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment
RECRUITING · Phase 3
-
Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype
COMPLETED · Phase 3
-
Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).
COMPLETED · Phase 3
-
Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation
COMPLETED · Phase 3
-
Nicotine Mouth Film for Craving Relief.
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05580419 · 1,188 participants · NA
Impact of 4PCP on Practitioner and Patient Outcomes
- NCT04293562 · 1,186 participants · Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- NCT07286058 · 1,182 participants · Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- NCT07177339 · 1,196 participants · Phase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI